Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy

Movement Disorders

Volumn 21, Issue 2, 2006, Pages 199-207

  Millar, David ^a,b   Griffiths, Philipa ^b   Zermansky, Adam J ^a   Burn, David J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Hunters Moor Regional Rehabilitation Centre   (United Kingdom)

Author keywords

Dysexecutive syndrome; Katz Adjustment Scale Relatives; PSP

Indexed keywords

ANXIETY; APATHY; ARTICLE; BEHAVIOR CHANGE; CLINICAL ARTICLE; COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC REASONING; EMOTION; FEMALE; FLUENCY DISORDER; FRONTAL LOBE; FUNCTIONAL ASSESSMENT; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INDEPENDENCE; KATZ ADJUSTMENT SCALES; MALE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOMETRY; PSYCHOSOCIAL WITHDRAWAL; WORKING MEMORY;

AFFECTIVE SYMPTOMS; AGED; ATTENTION; AWARENESS; COGNITION DISORDERS; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PERSONALITY ASSESSMENT; PREFRONTAL CORTEX; PROBLEM SOLVING; REACTION TIME; SET (PSYCHOLOGY); SUPRANUCLEAR PALSY, PROGRESSIVE; VERBAL BEHAVIOR;

EID: 33644953800     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20707     Document Type: Article

References (62)

1. Grafman J, Litvan I, Gomez C, Thomas N, Chase N. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990;47: 553-558.
2. Stuss DT, Levine B. Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol 2002;53:401-433.
3. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-880.
4. Chow TW, Cummings JL. Frontal-subcortical circuits. In: Miller BL, Cummings JL, editors. The human frontal lobes functions and disorders. New York: The Guilford Press; 1999. p 3-26.
5. Berthier ML, Kulisevsky J, Gironell A, Heras JA. Obsessive-compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function, and anatomic correlates. Neurology 1996;47:353-361.
6. Bogousslavsky J, Regli F. Anterior cerebral artery territory infarction in the Lausanne stroke registry. Arch Neurol 1990;47:144-150.
7. Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991;50:743-755.
8. Damasio H, Damasio AR. Lesion analysis in neuropsychology. New York: Oxford University Press; 1989. 256 p.
9. Leimkuhler ME, Mesulam MM. Reversible go-no go deficits in a case of frontal lobe tumor. Ann Neurol 1985;18:617-619.
10. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964;10:333-359.
11. Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001;124:1438-1449.
12. Bak TH, Hodges JR. The neuropsychology of progressive supranuclear palsy. Neurocase 1998;4:89-94.
13. Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranuclear palsy neuropathological and clinical heterogeneity. Neurology 1993;44:1015-1024.
14. Albert ML, Feldman RG, Willis AL. The "subcortical dementia" of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974;37:121-130.
15. Monza D, Soliveri P, Radice D, Fetoni V, Testa D, Caffarra P, Caraceni T, Girotti F. Cognitive dysfunction and impaired organization of complex motility in degenerative parkonsonian syndromes. Arch Neurol 1998;55:372-378.
16. Pillon B, Dubois B, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Ann N Y Acad Sci 1991;640:224-227.
17. Soliveri P, Monza D, Paridi D, Radice D, Grisoli M, Testa D, Savoiardo M, Girotti F. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999;53:502-507.
18. Robbins TW, James M, Owen AM, Lange KW, Lees AJ, Leigh PN, Marsden CD, Quinn NP, Summers BA. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. The J Neurol Neurosurg Psychiatry 1994;57:79-88.
19. Esmonde T, Giles E, Gibson M, Hodges JR. Neuropsychological performance, disease severity and depression in progressive supranuclear palsy. J Neurol 1996;243:638-643.
20. Litvan I, Grafman J, Gomez C, Chase TN. Memory impairment in patients with progressive supranuclear palsy. Arch Neurol 1989; 46:765-767.
21. Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13:42-49.
22. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I. Apathy is not depression. J Neuropsychiatry 1998;10:314-319.
23. Litvan I, Paulsen J, Mega M, Cummings J, Jeffrey L. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol 1998;55:1313-319.
24. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996;47: 1184-1189.
25. Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986;36:1179-1185.
26. Katz MM, Lyerly SB. Methods for measuring adjustment and social behavior in the community: rational, description, discriminative validity and scale development. Psychol Rep 1963;13:503-535.
27. Jackson HF, Hopewell CA, Glass CA, Warburg R, Dewey M, Ghadiali E. The Katz Adjustment Scale: modification for use with victims of brain and spinal injury. Brain Inj 1992;6:109-127.
28. Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ. Behavioural assessment of the dysexecutive syndrome. Bury St Edmunds: Thames Valley Test Corporation; 1996.
29. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC. Clinical research criteria for the diagnosis of progressive supranuclear palsy. Neurology 1996;46:1-9.
30. Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999;53:1292-1299.
31. Crawford JR, Allan KM, Cochrane RH, Parker DM. Assessing the validity of NART estimated premorbid IQs in the individual case. Br J Clin Psychol 1990;29:435-436.
32. Snaith RP, Zigmond AS. Hospital anxiety and depression scale. Acta Psychiatr 1994;63:361-370.
33. Burgess PW, Shallice T. Response suppression, initiation and strategy use following frontal lobe lesions. Neuropsychologia 1996;34:263-273.
34. Stuss DT, Eskes GA, Forster JK. Experimental neuropsychological studies of frontal lobe functions. In: Boller F, Grafman J, editors. Handbook of neuropsychology. Amsterdam: Elsevier Science Publishers; 1992. p 149-185.
35. Miceli G, Caltagirone C, Gainotti G, Masullo C, Silveri MC. Neuropsychological correlates of localized cerebral lesions in non-aphasic brain-damaged patients. J Clin Neuropsychol 1981;3:53-63.
36. Parks RW, Lowenstein DA, Dodrill KL, Barker WW, Yoshii F, Chang JY, Emran A, Apicella A, Sheramata WA, Duara R. Cerebral metabolic effects of a verbal fluency test: a PET scan study. J Clin Exp Neuropsychol 1988;10:565-575.
37. Cantor-Graae E, Warkentin S, Franzen G, Risberg J. Frontal lobe challenge: a comparison of activation procedures during rCBF measurement in normal subjects. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:83-92.
38. Warkentin S, Risberg J, Nilsson A, Karlson S, Graae E. Cortical activity during speech production: a study of regional cerebral blood flow in normal subjects performing a word task. Neuropsychiatry Neuropsychol Behav Neurol 1991;4:305-316.
39. Nathaniel-James DA, Fletcher P, Frith CD. The functional anatomy of verbal initiation and suppression using the Hayling Test. Neuropsychologia 1997;35:559-566.
40. Perret E. The left frontal lobe of man and the suppression of habitual responses in verbal categorical behavior. Neuropsychologia 1974;12:323-330.
41. Coughlan AK, Hollows SE. The adult memory and information processing battery. Leeds: Psychology Department, St James's University; 1985.
42. Archibald CJ, Fisk JD. Information processing efficiency in patients with multiple sclerosis. J Clin Exp Neuropsychol 2000;22: 686-701.
43. Groen G. Cognitive slowing in patients with acquired brain damage: an experimental approach. J Clin Exp Neuropsychol 1996;18: 406-415.
44. Nebes RD, Brady CB, Reynolds F. Cognitive slowing in Alzheimer's disease and geriatric depression. J Gerontol 1992;47:331-336.
45. Dubois B, Pillon B, Legault F, Agid Y, Lhermitte F. Slowing of cognitive processing in progressive supranuclear palsy: a comparison with Parkinson's disease. Arch Neurol 1988;45:1194-1199.
46. Burgess PW, Alderman N, Evans J, Emslie H, Wilson BA. The ecological validity of tests of executive function. J Int Neuropsychol Soc 1998;4:547-558.
47. Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004;75:246-249.
48. Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy - a clinical cohort study. Neurology 2003;60:910-916.
49. Agid Y, Javoy-Agid F, Ruberg M, Pillon B, Dubois B, Duyckaerts C, Hauw JJ, Baron JC, Scatton B. Progressive supranuclear palsy: anatomical and biochemical considerations. Adv Neurol 1987;45: 191-206.
50. Litvan I. Extrapyramidal disorders and frontal lobe function. In: Miller BL, Cummings JL, eds. The human frontal lobes functions and disorders. New York: The Guilford Press; 1999. p 402-421.
51. Cummings JL, Diaz C, Levy ML, Binetti G, Litvan I. Behavioural syndromes in neurodegenerative diseases: frequency and significance. Semin Neuropsychiatry 1996;1:241-247.
52. Perry RJ, Miller BL. Behavior and treatment in frontotemporal dementia. Neurology 2001;56(Suppl.):46-51.
53. Starkstein SE, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001; 158:872-877.
54. Migneco O, Benoit M, Koulibaly PM, Dygai I, Bertogliati C, Desvignes P, Robert PH, Malandain G, Bussiere F, Darcourt J. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer's disease and nondemented patients. Neuroimage 2001;13: 896-902.
55. Rapoport MJ, Van Reekum R, Freedman M, Streiner D, Simard M, Clarke D, Cohen T, Conn D. Relationship of psychosis to aggression, apathy, and function in dementia. Int J Geriatr Psychiatry 2001;16:123-130.
56. Ferretti L, McCurry SM, Logsdon R, Gibbons L, Teri L. Anxiety and Alzheimer's disease. J Geriatr Psychiatry Neurol 2001;14:52-58.
57. Burgess PW. Theory and methodology in executive function research. In: Rabbitt P, editor. Methodology of frontal and executive function. Hove: Erlbaum; 1997. p 81-116.
58. Schneider J, Murray J, Banerjee S, Mann A. A cross-national study of co-resident spouse carers for people with Alzheimer's disease: factors associated with carer burden. Int J Geriatr Psychiatry 1999; 14:651-661.
59. Miller E, Berrios GE, Politynska BE. Caring for someone with Parkinson's disease: factors that contribute to distress. Int J Geriatr Psychiatry 1996;11:263-268.
60. Uttl B, Santacruz P, Litvan I, Grafman J. Caregiving in progressive supranuclear palsy. Neurology 1998;51:1245-1246.
61. Cockburn J, Keene J, Hope T, Smith P. Progressive decline in NART score with increasing dementia severity. J Clin Exp Neuropsychol 2000;22:508-517.
62. Bak TH. Progressive supranuclear palsy (PSP). Europe international workshop: overall meeting report. Mov Disord 1996:264-373.